DOI: 10.1146/annurev-publhealth-040617-013638 60
Growing up, I always wanted to help people, he stressed
Key findings: 12 mg dose: Average weight loss of 24.2% of body weight (approximately 58 lbs for a 240 lb individual) 8 mg dose: Average weight loss of 22.8% 4 mg dose: Average weight loss of 17.0% Placebo: Average weight loss of 2.1% Over 90% of participants receiving the 8 mg or 12 mg dose lost at least 10% of body weight Over 75% of participants at the highest dose lost at least 20% of body weight Significant improvements in waist circumference, blood pressure, and lipid profiles were observed across dose groups Phase 2 Trial in Type 2 Diabetes A separate phase 2 trial evaluated retatrutide in adults with type 2 diabetes and obesity (Rosenstock et al., Lancet , 2023)
Recent innovations, such as new subcutaneous injection devices and inhalable formulations, cater to patient preferences for convenience and needle-free options
Consider Adjustments: If semaglutide is linked to your back pain, your doctor may adjust your dosage or suggest alternative treatments
But volume is only one part of the equation